The PREEMIE Reauthorization Act of 2025 extends research funding for prematurity, mandates the establishment of an interagency working group, and commissions a comprehensive study on the costs, causes, and prevention strategies for preterm births.
Michael Bennet
Senator
CO
The PREEMIE Reauthorization Act of 2025 extends critical federal research funding for preterm labor and the care of low birthweight infants through fiscal year 2029. It mandates the establishment of an interagency working group to coordinate efforts related to prematurity. Furthermore, the bill requires a comprehensive study by the National Academies on the financial costs, causes, prevention, and support opportunities related to preterm births.
The PREEMIE Reauthorization Act of 2025 is all about doubling down on federal efforts to tackle premature births, which remain a huge public health challenge. Essentially, this bill restarts the engine on a critical research program and mandates a deep dive into the financial and medical realities of babies born too early. It extends the authority to fund research on preterm labor and the care of low birthweight infants for another five years—specifically, covering fiscal years 2025 through 2029 (Sec. 2). If you’re a researcher, a parent of a preemie, or just someone who pays taxes, this means the government is committing to continued investment in finding better answers.
Think of this section as securing the budget for the people trying to figure out why one in ten babies is born prematurely. The original law authorizing this research was set to expire, but this bill ensures that the federal government can continue to authorize funding for these studies for the next half-decade. This stability is huge for scientists who need long-term certainty to tackle complex medical problems. For families, this means the research pipeline—the one that develops new treatments and better care practices for NICU stays and beyond—stays open.
Sometimes, the biggest hurdle in government is getting different agencies to work together. The 2018 version of this law only suggested that the Secretary of Health and Human Services (HHS) set up an interagency working group on prematurity. This new bill changes the language from optional to mandatory. The Secretary must establish this group, working with other departments as needed, and they have a hard deadline: no later than 18 months after the bill becomes law (Sec. 3). This working group is designed to coordinate federal efforts, which should translate to less bureaucratic overlap and more effective policy delivery on the ground.
Perhaps the most impactful part of this legislation is the mandate for a comprehensive study on preterm births (Sec. 4). HHS is required to contract with the National Academies of Sciences, Engineering, and Medicine to convene an expert panel within 30 days of enactment. This group has 24 months to produce a massive report that will analyze three core areas.
First, they have to figure out the total financial burden of preterm births. This isn't just the cost of a NICU stay—it’s the long-term healthcare costs borne by families and society. If you’ve ever dealt with a complicated medical bill, you know how quickly those costs add up over years. This study will finally put a clear price tag on the issue.
Second, the experts must look into the causes and prevention strategies, focusing on ways to improve maternal and infant health. They need to analyze how targeted research can lead to better drugs and treatments to keep at-risk pregnancies going full-term. Third, they must assess existing public health programs and identify best practices among states that are successfully lowering their prematurity rates. This means looking at what’s working in the real world and providing a roadmap for everyone else.
For the average person, this study is crucial because it’s the data that drives policy change. When we know the true cost of an issue—not just in human terms, but in dollars—it makes a much stronger case for investment in prevention and better care. It also forces a look at how precision medicine and preventative care, starting early in life, could influence health outcomes well into adulthood.